Thinking of joining a study?

Register your interest

NCT04533919 | RECRUITING | Spinal Cord Neoplasm


Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
Sponsor:

M.D. Anderson Cancer Center

Brief Summary:

This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.

Condition or disease

Spinal Cord Neoplasm

Intervention/treatment

Biospecimen Collection

Detailed Description:

PRIMARY OBJECTIVE: I. To identify translational mechanisms and therapeutics for neuropathic pain, a type of chronic pain that can arise due to injured nerves. OUTLINE: Patients' leftover dorsal root ganglia samples are collected during standard of care surgery.

Study Type : OBSERVATIONAL
Estimated Enrollment : 8 participants
Official Title : Validation of Pre-Clinical Nano-Based Analgesics in Cells From Dorsal Root Ganglia
Actual Study Start Date : 2020-06-16
Estimated Primary Completion Date : 2027-04-30
Estimated Study Completion Date : 2027-04-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • ---All patients undergoing surgery to resect spinal tumors
Exclusion Criteria
  • ---None

Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Location Details

NCT04533919


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Texas

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Loading...